Enzyme-linked immunosorbent assay for pharmacological studies targeting hypoxia-inducible factor 1α

Clinical and Diagnostic Laboratory Immunology

Volumn 12, Issue 5, 2005, Pages 660-664

  Formento, J L ^a,e   Berra, E ^b   Ferrua, B ^c   Magne N ^a   Simos, G ^d   Brahimi Horn, C ^b   Pouyssegur J ^b   Milano, G ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b CNRS   (France)

^c School of Medicine   (France)

^d UNIVERSITY OF THESSALY   (Greece)

^e Oncopharmacology Unit Centre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADAPTATION; ANALYTIC METHOD; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; METABOLISM; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL CULTURE; TUMOR CELL LINE; VALIDATION PROCESS; WESTERN BLOTTING;

ANOXIA; CELL LINE, TUMOR; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM PROTEINS; NUCLEAR PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 23944492884     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.12.5.660-664.2005     Document Type: Article

References (26)

1. Bachtiary, B., M. Schindl, R. Pötter, B. Dreier, T. H. Knocke, J. A. Hainfellner, R. Horvat, and P. Birner. 2003. Overexpression of hypoxia-inducible factor 1 α indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin. Cancer Res. 9:2234-2240.
2. Berchner-Pfannschmidt, U., Petrat, F., K. Doege, B. Trinidad, P. Freitag, E. Metzen, de H. Groot, and J. Fandrey. 2004. Chelation of cellular calcium modulates hypoxia-inducible gene expression through activation of hypoxia-inducible factor-1 alpha. J. Biol. Chem. 279:44976-44986.
3. Birner, P., B. Gatterbauer, G. Oberhuber, M. Schindl, K. Rossler, A. Prodinger, H. Budka, and J. A. Hainfellner. 2002. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer 92:165-171.
4. Bos, R., van der P. Groep, A. E. Greijer, A. Shvarts, S. Meijer, H. M. Pinedo, G. L. Semenza, P. J. van Diest, and E. van der Wall. 2003. Levels of hypoxia-inducible factor-1 alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97:1573-1581.
5. Brizel, D. M., S. P. Scully, J. M. Harrelson, L. J. Layfield, J. M. Bean, L. R. Prosnitz, and M. W. Dewhirst. 1996. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56:941-943.
6. Du, Z., C. Fujiyama, Y. Chen, and Z. Masaki. 2003. Expression of hypoxia-inducible factor 1 alpha in human normal, benign and malignant prostatic tissue. Chin. Med. J. (Engl.) 116:1936-1939.
7. Giaccia, A., B. G. Siim, and R. S. Johnson. 2003. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2:803-811.
8. Giatromanolaki, A., M. I. Koukourakis, E. Sivridis, H. Turley, K. Talks, F. Pezzella, K. C. Gatter, and A. L. Harris. 2001. Relation of hypoxia-inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br. J. Cancer 85:881-890.
9. Hon, W. C., M. I. Wilson, K. Harlos, T. D. Claridge, C. J. Schofield, C. W. Pugh, P. H. Maxwell, P. J. Ratcliffe, D. I. Stuart, and E. Y. Jones. 2002. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature 417:975-980.
10. Jeong, J. W., M. K. Bae, M. Y. Ahn, S. H. Kim, T. K. Sohn, M. H. Bae, M. A. Yoo, E. J. Song, K. J. Lee, and K. W. Kim. 2002. Regulation and destabilization of HIF-1 alpha by ARD1-mediated acetylation. Cell 111:709-720.
11. Koukourakis, M. I., A. Giatromanolaki, J. Skarlatos, L. Corti, S. Blandamura, M. Piazza, K. C. Gatter, and A. L. Harris. 2001. Hypoxia-inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 61:1830-1832.
12. Le, Q. T., and A. J. Giaccia. 2003. HIF-alpha, a gender independent transcription factor. Clin. Cancer Res. 9:2391-2393.
13. Palayoor, S. T., M. A. Burgos, A. Shoaibi, P. J. Tofilon, and C. N. Coleman. 2004. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene fonction. Clin. Cancer Res. 10:4158-4164.
14. Paul, S. A., J. W. Simons, and N. J. Mabjeesh. 2004. HIF at the crossroads between ischemia and carcinogenesis. J. Cell. Physiol. 200:20-30.
15. Powis, G., and L. Kirkpatrick. 2004. Hypoxia inducible factor-1 alpha as a cancer drug target. Mol. Cancer Ther. 3:647-654.
16. Quintero, M., N. Mackenzie, and P. A. Brennan. 2004. Hypoxia-inducible factor 1(HIF-1) in cancer. Eur. J. Surg. Oncol. 30:465-468.
17. Richard, D. E., E. Berra, E. Gothie, D. Roux, and J. Pouyssegur. 1999. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1 alpha (HIF-1 alpha) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274:32631-32637.
18. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell. Dev. Biol. 15:551-578.
19. Semenza, G. L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3:721-732.
20. Sutler, C. H., E. Laughner, and G. Semenza. 2000. Hypoxia-inducible factor 1 protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. USA 97:4748-4753.
21. Trash-Bingham, C. A., and K. D. Tartof. 1999. aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J. Natl. Cancer Inst. 91:143-151.
22. Ugurel, S., G. Rappl, W. Tilgen, and U. Reinhold. 2001. Increased serum concentrations of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J. Clin. Oncol. 19:577-583.
23. 2 tension. Proc. Natl. Acad. Sci. USA 92:5510-5514.
24. Welsh, S. J., and G. Powis. 2003. Hypoxia inducible factor as a cancer drug target. Curr. Cancer Drug Targets 3:391-405.
25. Yeo, E. J., Y. S. Chun and J. W. Park. 2004. New anticancer strategies targeting HIF-1α. Biochem. Pharmacol. 68:1061-1069.
26. Zhang, Q., Z. F. Zhang, J. Y. Rao, J. D. Sato, J. Brown, D. V. Messadi, and A. D. Le. 2004. Treatment with siRNA and antisense oligonucleotides targeted to HIF-1 alpha induced apoptosis in human tongue squamous cell carcinomas. Int. J. Cancer 111:849-857.